NCT01674270View on ClinicalTrials.gov

Degarelix Neo-Adjuvant Radical Prostatectomy Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

November 30, 2015

Conditions
Prostate Cancer
Interventions
DRUG

Degarelix

DRUG

Casodex

DRUG

LHRH Agonist

Trial Locations (2)

Unknown

Vancouver General Hospital, Vancouver

M5G 2M9

University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT01674270 - Degarelix Neo-Adjuvant Radical Prostatectomy Trial | Biotech Hunter | Biotech Hunter